ATE353964T1 - Crsp-proteine (cystein-reiche, sekretierte proteine), die dafür kodierenden nukleinsäuren und ihre verwendungen - Google Patents
Crsp-proteine (cystein-reiche, sekretierte proteine), die dafür kodierenden nukleinsäuren und ihre verwendungenInfo
- Publication number
- ATE353964T1 ATE353964T1 AT98918453T AT98918453T ATE353964T1 AT E353964 T1 ATE353964 T1 AT E353964T1 AT 98918453 T AT98918453 T AT 98918453T AT 98918453 T AT98918453 T AT 98918453T AT E353964 T1 ATE353964 T1 AT E353964T1
- Authority
- AT
- Austria
- Prior art keywords
- crsp
- proteins
- nucleic acid
- encod
- cystein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Oncology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Psychology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Virology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84370497A | 1997-04-16 | 1997-04-16 | |
US84289897A | 1997-04-17 | 1997-04-17 | |
US7158998P | 1998-01-15 | 1998-01-15 | |
US980298A | 1998-01-20 | 1998-01-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE353964T1 true ATE353964T1 (de) | 2007-03-15 |
Family
ID=27485904
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06021943T ATE505543T1 (de) | 1997-04-16 | 1998-04-16 | Zusammensetzung, umfassend einen antikörper, der selektiv an ein cysteinreiches sekretiertes protein (crsp) bindet |
AT98918453T ATE353964T1 (de) | 1997-04-16 | 1998-04-16 | Crsp-proteine (cystein-reiche, sekretierte proteine), die dafür kodierenden nukleinsäuren und ihre verwendungen |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06021943T ATE505543T1 (de) | 1997-04-16 | 1998-04-16 | Zusammensetzung, umfassend einen antikörper, der selektiv an ein cysteinreiches sekretiertes protein (crsp) bindet |
Country Status (11)
Country | Link |
---|---|
EP (3) | EP0975755B2 (de) |
JP (4) | JP2001524824A (de) |
AT (2) | ATE505543T1 (de) |
AU (2) | AU7137398A (de) |
CA (1) | CA2288430C (de) |
CY (1) | CY1107629T1 (de) |
DE (2) | DE69837085T3 (de) |
DK (1) | DK0975755T3 (de) |
ES (1) | ES2285768T5 (de) |
PT (1) | PT975755E (de) |
WO (1) | WO1998046755A1 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7057017B2 (en) | 1997-04-16 | 2006-06-06 | Millennium Pharmaceuticals, Inc. | Human dickkopf-related protein and nucleic acid molecules and uses therefor |
EP1378571B1 (de) * | 1997-08-01 | 2011-01-12 | Merck Serono Biodevelopment | 5' ESTs für sekretierte Proteine, die in verschiedenen Geweben exprimiert werden |
DE19747418C1 (de) * | 1997-10-27 | 1999-07-15 | Deutsches Krebsforsch | Inhibitor-Protein des wnt-Signalwegs |
US7446181B2 (en) | 1998-01-15 | 2008-11-04 | Millennium Pharmaceuticals, Inc. | Antibodies that bind human Dickkopf-1 proteins |
US6344541B1 (en) * | 1998-09-25 | 2002-02-05 | Amgen Inc. | DKR polypeptides |
DK1124949T3 (da) * | 1998-10-26 | 2006-11-06 | Novozymes As | Konstruktion og screening af et DNA-bibliotek af interesse i trådformede svampeceller |
EP1161445A2 (de) * | 1999-03-05 | 2001-12-12 | Millennium Pharmaceuticals, Inc. | Menschliche dickkopf-verwandte proteine und nukleinsäuremoleküle und deren verwendungen |
US7115665B1 (en) | 2000-11-16 | 2006-10-03 | Onocozyme Pharma, Inc. | Inhibitors of endo-exonuclease activity for treating cancer |
WO2001038528A1 (fr) * | 1999-11-19 | 2001-05-31 | Hisamitsu Pharmaceutical Co., Inc. | Proteine inhibitrice de la proliferation cellulaire, polynucleotide, polynucleotide antisens de ce polynucleotide, inhibiteurs de proliferation cellulaire, diagnostics de cancers, remedes anticancereux et composition pour therapie genique les utilisant |
WO2001063295A2 (en) * | 2000-02-24 | 2001-08-30 | Oxford Glycosciences (Uk) Ltd. | Dpi-6, a therapeutic biomarker in neurological disorders |
AU2002318112B2 (en) | 2001-04-10 | 2007-12-06 | Agensys, Inc. | Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
US7927597B2 (en) | 2001-04-10 | 2011-04-19 | Agensys, Inc. | Methods to inhibit cell growth |
AU2002308557A1 (en) | 2001-05-01 | 2002-11-11 | The Regents Of The University Of California | Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas |
US20040038860A1 (en) | 2002-05-17 | 2004-02-26 | Allen Kristina M. | Reagents and methods for modulating dkk-mediated interactions |
US7622553B2 (en) | 2003-11-17 | 2009-11-24 | Merck & Co., Inc. | Rhesus monkey dickkopf-1, nucleotides encoding same, and uses thereof |
WO2005049797A2 (en) | 2003-11-17 | 2005-06-02 | Merck & Co., Inc. | Cynomolgus monkey dickkopf-4, nucleotides encoding same, and uses thereof |
WO2005095448A2 (en) | 2004-03-23 | 2005-10-13 | Oscient Pharmaceuticals Corporation | Method of synthesizing and purifying dkk proteins and dkk proteins obtained thereby |
CA2574881C (en) | 2004-08-04 | 2013-01-08 | Amgen Inc. | Antibodies to dkk-1 |
AR060017A1 (es) | 2006-01-13 | 2008-05-21 | Novartis Ag | Composiciones y metodos de uso para anticuerpos de dickkopf -1 |
US7465585B1 (en) | 2006-04-10 | 2008-12-16 | The Burnham Institute | Compositions and methods for inhibiting cell migration |
AR075989A1 (es) | 2009-04-10 | 2011-05-11 | Lilly Co Eli | Anticuerpo dkk -1 (dickkopf-1) humano disenado por ingenieria |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4873191A (en) | 1981-06-12 | 1989-10-10 | Ohio University | Genetic transformation of zygotes |
US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
US4870009A (en) | 1982-11-22 | 1989-09-26 | The Salk Institute For Biological Studies | Method of obtaining gene product through the generation of transgenic animals |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4736866A (en) | 1984-06-22 | 1988-04-12 | President And Fellows Of Harvard College | Transgenic non-human mammals |
JPS6147500A (ja) | 1984-08-15 | 1986-03-07 | Res Dev Corp Of Japan | キメラモノクロ−ナル抗体及びその製造法 |
EP0173494A3 (de) | 1984-08-27 | 1987-11-25 | The Board Of Trustees Of The Leland Stanford Junior University | Chimäre Rezeptoren durch Verbindung und Expression von DNS |
GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
JP2874751B2 (ja) | 1986-04-09 | 1999-03-24 | ジェンザイム・コーポレーション | 希望する蛋白質をミルク中へ分泌する遺伝子移植動物 |
US4902505A (en) | 1986-07-30 | 1990-02-20 | Alkermes | Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
US4987071A (en) | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
US5116742A (en) | 1986-12-03 | 1992-05-26 | University Patents, Inc. | RNA ribozyme restriction endoribonucleases and methods |
US4904582A (en) | 1987-06-11 | 1990-02-27 | Synthetic Genetics | Novel amphiphilic nucleic acid conjugates |
US4873316A (en) | 1987-06-23 | 1989-10-10 | Biogen, Inc. | Isolation of exogenous recombinant proteins from the milk of transgenic mammals |
US5080891A (en) | 1987-08-03 | 1992-01-14 | Ddi Pharmaceuticals, Inc. | Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
DE68927933T2 (de) | 1988-09-02 | 1997-08-14 | Dyax Corp | Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen |
US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
US5116964A (en) | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
US5225538A (en) | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
FR2646438B1 (fr) | 1989-03-20 | 2007-11-02 | Pasteur Institut | Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration |
US5328470A (en) | 1989-03-31 | 1994-07-12 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
US5459039A (en) | 1989-05-12 | 1995-10-17 | Duke University | Methods for mapping genetic mutations |
DE69033493D1 (de) | 1989-07-25 | 2004-08-12 | Cell Genesys Inc | Homologe rekombination für universelle donorzellen und chimerische säugetierzellen |
US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
JPH06508511A (ja) | 1990-07-10 | 1994-09-29 | ケンブリッジ アンティボディー テクノロジー リミティド | 特異的な結合ペアーの構成員の製造方法 |
GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
US5393788A (en) | 1990-07-10 | 1995-02-28 | Smithkline Beecham Corporation | Phenylalkyl oxamides |
AU9076191A (en) | 1990-11-21 | 1992-06-25 | Massachusetts Institute Of Technology | Mice having beta 2 microglobulin gene disruption |
DE69129154T2 (de) | 1990-12-03 | 1998-08-20 | Genentech, Inc., South San Francisco, Calif. | Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften |
EP0575485A1 (de) | 1991-03-01 | 1993-12-29 | Dyax Corp. | Verfahren zur entwicklung bindender miniproteine |
JP3672306B2 (ja) | 1991-04-10 | 2005-07-20 | ザ スクリップス リサーチ インスティテュート | ファージミドを使用するヘテロ二量体受容体ライブラリー |
CA2580812A1 (en) | 1991-06-27 | 1993-01-07 | Bristol-Myers Squibb Company | Ctla4 receptor, fusion proteins containing it and uses thereof |
DE4122599C2 (de) | 1991-07-08 | 1993-11-11 | Deutsches Krebsforsch | Phagemid zum Screenen von Antikörpern |
AU2515992A (en) | 1991-08-20 | 1993-03-16 | Genpharm International, Inc. | Gene targeting in animal cells using isogenic dna constructs |
CA2148252C (en) | 1992-10-30 | 2007-06-12 | Roger Brent | Interaction trap system for isolating novel proteins |
JPH08509857A (ja) | 1993-01-07 | 1996-10-22 | シーケノム・インコーポレーテッド | マススペクトロメトリーによるdna配列決定法 |
JP2879303B2 (ja) * | 1993-01-14 | 1999-04-05 | 佑 本庶 | cDNAライブラリーの作製方法、および新規なポリペプチドとそれをコードするDNA |
US5498531A (en) | 1993-09-10 | 1996-03-12 | President And Fellows Of Harvard College | Intron-mediated recombinant techniques and reagents |
JP2001507227A (ja) * | 1996-12-20 | 2001-06-05 | ヒューマン ジノーム サイエンシーズ,インコーポレイテッド | 小脳および胚に特異的なタンパク質 |
DE19747418C1 (de) * | 1997-10-27 | 1999-07-15 | Deutsches Krebsforsch | Inhibitor-Protein des wnt-Signalwegs |
IT1395574B1 (it) | 2009-09-14 | 2012-10-16 | Guala Dispensing Spa | Dispositivo di erogazione |
-
1998
- 1998-04-16 AT AT06021943T patent/ATE505543T1/de not_active IP Right Cessation
- 1998-04-16 DK DK98918453T patent/DK0975755T3/da active
- 1998-04-16 JP JP54436198A patent/JP2001524824A/ja active Pending
- 1998-04-16 ES ES98918453T patent/ES2285768T5/es not_active Expired - Lifetime
- 1998-04-16 WO PCT/US1998/007894 patent/WO1998046755A1/en active IP Right Grant
- 1998-04-16 EP EP98918453A patent/EP0975755B2/de not_active Expired - Lifetime
- 1998-04-16 AT AT98918453T patent/ATE353964T1/de active
- 1998-04-16 PT PT98918453T patent/PT975755E/pt unknown
- 1998-04-16 EP EP10010403A patent/EP2298899A3/de not_active Withdrawn
- 1998-04-16 AU AU71373/98A patent/AU7137398A/en not_active Abandoned
- 1998-04-16 CA CA2288430A patent/CA2288430C/en not_active Expired - Lifetime
- 1998-04-16 DE DE69837085T patent/DE69837085T3/de not_active Expired - Lifetime
- 1998-04-16 EP EP06021943A patent/EP1852507B1/de not_active Expired - Lifetime
- 1998-04-16 DE DE69842225T patent/DE69842225D1/de not_active Expired - Lifetime
-
2005
- 2005-12-22 JP JP2005370262A patent/JP2006166917A/ja active Pending
-
2007
- 2007-05-14 CY CY20071100650T patent/CY1107629T1/el unknown
-
2009
- 2009-08-17 JP JP2009188614A patent/JP2010011853A/ja active Pending
- 2009-10-22 AU AU2009227915A patent/AU2009227915A1/en not_active Abandoned
-
2010
- 2010-05-13 JP JP2010111163A patent/JP2010227110A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0975755B9 (de) | 2007-08-29 |
DE69837085T2 (de) | 2007-11-22 |
AU2009227915A1 (en) | 2009-11-12 |
PT975755E (pt) | 2007-06-26 |
DE69837085D1 (de) | 2007-03-29 |
ATE505543T1 (de) | 2011-04-15 |
CA2288430A1 (en) | 1998-10-22 |
JP2010227110A (ja) | 2010-10-14 |
JP2001524824A (ja) | 2001-12-04 |
CY1107629T1 (el) | 2013-06-19 |
EP0975755B2 (de) | 2011-08-03 |
JP2006166917A (ja) | 2006-06-29 |
AU7137398A (en) | 1998-11-11 |
DK0975755T3 (da) | 2007-06-11 |
EP1852507B1 (de) | 2011-04-13 |
ES2285768T3 (es) | 2007-11-16 |
CA2288430C (en) | 2013-04-09 |
EP0975755A1 (de) | 2000-02-02 |
ES2285768T5 (es) | 2011-12-22 |
EP2298899A3 (de) | 2011-08-24 |
DE69842225D1 (de) | 2011-05-26 |
EP2298899A2 (de) | 2011-03-23 |
WO1998046755A1 (en) | 1998-10-22 |
JP2010011853A (ja) | 2010-01-21 |
DE69837085T3 (de) | 2012-01-12 |
EP0975755B1 (de) | 2007-02-14 |
EP1852507A1 (de) | 2007-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE353964T1 (de) | Crsp-proteine (cystein-reiche, sekretierte proteine), die dafür kodierenden nukleinsäuren und ihre verwendungen | |
FR19C1020I1 (fr) | Nouvelles molecules b7-4 et leurs utilisations | |
WO1999066025A3 (en) | Mtbx protein and nucleic acid molecules and uses therefor | |
ATE366814T1 (de) | Gl50 moleküle, sowie verwendungen derselben | |
ATE356137T1 (de) | Neue moleküle aus der familie der tango-77- ähnlichen proteine und ihre verewendungen. | |
WO2002070652A3 (en) | Novel molecules of the card-related protein family and uses thereof | |
ATE419358T1 (de) | Gebrauchsverfaheren eines neuen lysyloxidase- verwandten proteins | |
WO2000052047A3 (en) | Human dickkopf-related protein and nucleic acid molecules and uses therefor | |
WO2002044354A3 (en) | Molecules of the card-related protein family and uses thereof | |
WO2001000826A3 (en) | Novel molecules of the card-related protein family and uses thereof | |
WO2000019988A8 (en) | NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF | |
DE60031418D1 (de) | 15571, ein neues gpcr-ähnliches molekül der secretin-ähnlichen familie und dessen verwendungen | |
WO2000012544A3 (en) | Novel irap-bp polypeptide and nucleic acid molecules and uses therefor | |
WO2001018216A3 (en) | 26176, a novel calpain protease and uses thereof | |
WO2000008045A3 (en) | Novel molecules of the tango-93-related protein family and uses thereof | |
WO1999054437A3 (en) | Novel molecules of the t125-related protein family and uses thereof | |
WO2001030971A3 (en) | Novel molecules and the card-related protein family and uses thereof | |
WO2001077151A3 (en) | Fdrg proteins and nucleic acid molecules and uses therefor | |
WO2002085939A8 (en) | Novel molecules of the card-related protein family and uses thereof | |
WO2000018890A3 (en) | Protein phosphatase molecules and uses therefor | |
WO2001073074A3 (en) | 18806, a novel trypsin serine protease-like molecule and uses thereof | |
WO1999062943A3 (en) | Novel molecules of the aip-related protein family and uses thereof | |
WO2001083523A3 (en) | Stmst protein and nucleic acid molecules and uses therefor | |
WO1999067387A3 (en) | Novel mp-7 protein and nucleic acid molecules and uses therefor | |
WO2001040468A3 (en) | Molecules of the card-related protein family and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0975755 Country of ref document: EP |